Dr Rob Forsyth
Consultant/Senior Lecturer

  • Email: rob.forsyth@ncl.ac.uk
  • Telephone: +44 (0) 191 282 5742
  • Fax: +44 (0) 191 282 4878
  • Address: Institute of Neuroscience, Sir James Spence Institute, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP


Rob Forsyth is a specialist paediatric (child) neurologist and researcher in aspects of brain disease in children. He is a Senior Lecturer at Newcastle University and also an NHS Consultant Paediatric Neurologist at the Great North Children's Hospital, Newcastle upon Tyne. His clinical work includes management of neurological conditions in children both in outpatient and inpatient settings, including paediatric neurointensive care.

His main research interest is acquired brain injury in children: how to prevent it, how best to treat it in the early intensive care phase and above all how best to optimise outcomes through rehabilitation. He is developing methods to allow careful, systematic clinical trials of novel rehabilitation treatments to see if they improve outcome.

He also collaborates with basic scientists in Newcastle and elsewhere exploring novel treatments for epilepsies in childhood

He was UK national training advisor in paediatric neurology 2003-9 and co-edited the Oxford Specialist Handbook in Paediatric Neurology (second edition due March 2012). He was on the editorial board of the journal Developmental Medicine and Child Neurology from 2004-2011. He is a Trustee of the UK Children's Neurological Research Campaign

Previous Positions

Jan - Dec 1997. Fellow, Department of Paediatric Neurology, British Columbia Children's Hospital and University of British Columbia, Vancouver, Canada

1995-1996. First Assistant, Newcastle University

1991-1994. Wellcome Clinical Research Fellow, Newcastle University 



Research Interests

Optimisation of recovery from acquired brain injury in children. Measurement of participation of disabled children, and of factors affecting this.

Other Expertise

Paediatric rehabilitation, epilepsy


2011-2015. Phase 1 trial of 5% carbogen in the management of paediatric non-convulsive status epilepticus. Epilepsy Research UK. £25k.

Senior editor,  Oxford Specialist Handbook of Paediatric Neurology 2007 (second edition in press). Oxford University Press.

Former National Training Adviser in Paediatric Neurology 2004-2010.